The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GEMSTONE-201: Preplanned primary analysis of a multicenter, single-arm, phase 2 study of sugemalimab (suge) in patients (pts) with relapsed or refractory extranodal natural killer/T cell lymphoma (R/R ENKTL).
 
Huiqiang Huang
No Relationships to Disclose
 
Rong Tao
No Relationships to Disclose
 
Yu Yang
No Relationships to Disclose
 
Hong Cen
No Relationships to Disclose
 
Hui Zhou
No Relationships to Disclose
 
Ye Guo
Honoraria - BMS; Merck Serono; MSD; Roche
Consulting or Advisory Role - Bayer; Merck Serono; MSD; Roche
 
Liqun Zou
No Relationships to Disclose
 
Junning Cao
No Relationships to Disclose
 
Yunhong Huang
No Relationships to Disclose
 
Jie Jin
No Relationships to Disclose
 
Liling Zhang
No Relationships to Disclose
 
Haiyan Yang
No Relationships to Disclose
 
Xiaojing Xing
No Relationships to Disclose
 
Huilai Zhang
No Relationships to Disclose
 
Yanyan Liu
No Relationships to Disclose
 
Xiaoli Zhu
Employment - CStone Pharmaceuticals
Stock and Other Ownership Interests - CStone Pharmaceuticals
 
Teng Fang
Employment - CStone Pharmaceuticals
 
Hangjun Dai
Employment - CStone Pharmaceuticals
 
Qinzhou Qi
Employment - CStone Pharmaceuticals
Stock and Other Ownership Interests - CStone Pharmaceuticals
 
Jason Yang
Employment - CStone Pharmaceuticals
Leadership - CStone Pharmaceuticals
Stock and Other Ownership Interests - CStone Pharmaceuticals